EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

LD-110, a potent LSD1 PROTAC degrader, suppresses tumor growth by inducing ER stress and apoptosis

Danyi Zhai, Jiezhen Zhuo, Yudong Yin, Lan Li, Mengting Liang, Xin Zhou, Lihua Liu, Liangzhen Chen, Xiufang Xiong, Qing Yu, Xin Han, Yi Sun

Science Bulletin · 2025

DOI: 10.1016/j.scib.2025.10.024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Bulletin, 2025. Verfasst von Danyi Zhai und 11 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), The Second Affiliated Hospital, Zhejia…. Hauptthemen laut MEDLINE: Endoplasmic Reticulum Stress, Apoptosis, Histone Demethylases, Antineoplastic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lysine-specific demethylase 1 (LSD1, also known as KDM1A) is frequently overexpressed in multiple cancer types and associated with poor prognosis of cancer patients. While LSD1 represents a compelling therapeutic target, clinical development of small-molecule inhibitors has been hampered by dose-limiting toxicities and off-target effects. In this study, we reported the discovery of LD-110 as a potent proteolysis targeting chimera (PROTAC) specifically engineered for LSD1 degradation. LD-110 effectively degrades LSD1 via the ubiquitin-proteasome system and significantly suppresses the growth and survival of breast and lung cancer cells. Mechanistically, LD-110 triggers endoplasmic reticulum stress by activating the ATF4-CHOP signal to increase NOXA levels, but decrease MCL1 levels, along with increasing ROS production and prolonged DNA damage to trigger phosphorylation of GCN2 and eIF2α for enhanced ATF4 translation, ultimately inducing apoptotic cell death. Importantly, LD-110 demonstrated a good in vivo pharmacokinetic profile and effectively inhibited in vivo tumor growth in breast and lung xenograft tumor models. Collectively, we discovered a potent PROTAC degrader targeting LSD1 with effective anti-cancer activity for future development as a promising anti-cancer agent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endoplasmic Reticulum StressApoptosisHistone DemethylasesAntineoplastic AgentsHumansAnimalsCell Line, TumorMiceXenograft Model Antitumor AssaysActivating Transcription Factor 4FemaleProteolysisCell ProliferationLung NeoplasmsTranscription Factor CHOPMice, NudeBreast NeoplasmsReactive Oxygen SpeciesProto-Oncogene Proteins c-bcl-2

Stichwörter der Autor:innen

ApoptosisCancer therapyEndoplasmic reticulum stressHistone H3K4 methylationsLSD1PROTAC degrader

Substanzen

Histone DemethylasesKDM1A protein, humanActivating Transcription Factor 4Antineoplastic AgentsATF4 protein, humanTranscription Factor CHOPReactive Oxygen SpeciesPMAIP1 protein, humanProto-Oncogene Proteins c-bcl-2

Autor:innen und Institutionen

  • Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China; Institute of…
  • SunnyInnovation Co. Ltd, Hangzhou 310030, China.
  • SunnyInnovation Co. Ltd, Hangzhou 310030, China. Electronic address: yuqing@sunnyinnov.com.

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Zhai, D., Zhuo, J., Yin, Y., Li, L., Liang, M., Zhou, X., Liu, L., Chen, L., Xiong, X., Yu, Q., Han, X., & Sun, Y. (2025). LD-110, a potent LSD1 PROTAC degrader, suppresses tumor growth by inducing ER stress and apoptosis. Science Bulletin. https://doi.org/10.1016/j.scib.2025.10.024

Vancouver

Zhai D, Zhuo J, Yin Y, Li L, Liang M, Zhou X, et al. LD-110, a potent LSD1 PROTAC degrader, suppresses tumor growth by inducing ER stress and apoptosis. Science Bulletin. 2025. doi:10.1016/j.scib.2025.10.024

BibTeX
@article{Zhai2025,
  author = {Zhai, Danyi and Zhuo, Jiezhen and Yin, Yudong and Li, Lan and Liang, Mengting and Zhou, Xin and Liu, Lihua and Chen, Liangzhen and Xiong, Xiufang and Yu, Qing and Han, Xin and Sun, Yi},
  title = {LD-110, a potent LSD1 PROTAC degrader, suppresses tumor growth by inducing ER stress and apoptosis},
  journal = {Science Bulletin},
  year = {2025},
  doi = {10.1016/j.scib.2025.10.024}
}
Kostenlos starten →